FDA

FDA Issues Final Guidance for 3-D Printing

By MedTech Intelligence Staff
No Comments
FDA

Recognizing that additive manufacturing is an emerging technology, the agency is providing an outline of its current thinking about the technical aspects of AM processes.

Today FDA issued the final version of its guidance on additive manufacturing. “Technical Considerations for Additive Manufactured Medical Devices”makes recommendations regarding device design, manufacturing and testing considerations when developing devices that have at least one component that is additively manufactured or there is an additively fabricated step in the process.

“The unique aspects of the AM process, such as the layer-by-layer fabrication process, combined with the relative lack of experience and clinical history with respect to devices manufactured using AM techniques, pose challenges in determining optimal characterization and assessment methods for the final finished device, as well as optimal process validation and verification methods for these devices.” – FDA

Next year FDA will host a webinar to review the guidance and answer questions. The event will take place on January 10 from 1–2:30 pm (Dial: 800-369-2040, passcode: 1397061).

About The Author

MedTech Intelligence

Leave a Reply

Your email address will not be published. Required fields are marked *